Page last updated: 2024-12-08
diazabicyclo(2.2.2)octane
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
diazabicyclo(2.2.2)octane: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 136165 |
SCHEMBL ID | 115270 |
MeSH ID | M0581552 |
Synonyms (18)
Synonym |
---|
1,2-diazabicyclo(2.2.2)octane |
1,2-diazabicyclo[2.2.2]octane |
329-94-2 |
AKOS015901957 |
1,7-diazabicyclo[2.2.2]octane |
QVCUKHQDEZNNOC-UHFFFAOYSA-N |
diazabicyclo(2.2.2)octane |
diazabicyclo[2.2.2]-octane |
diazabicyclo[2,2,2]octane |
diazabicyclo (2.2.2) octane |
diazabicyclo-[2,2,2]-octane |
diazabicyclo [2.2.2] octane |
diazabicyclo[2.2.2]octane |
diazabicyclo [2.2.2]octane |
SCHEMBL115270 |
DTXSID40186554 |
1,2-diaza-bicyclo[2.2.2]octane |
4-diazabicyclo[2.2.2]octane |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 4 (50.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 43.97
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.
| This Compound (43.97) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 1 (12.50%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 7 (87.50%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |